We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.5M
AUM Growth
-$1.25M
Cap. Flow
-$864K
Cap. Flow %
-0.88%
Top 10 Hldgs %
73.45%
Holding
23
New
3
Increased
–
Reduced
–
Closed
2
Avg Time Held
8 quarters
Top 10 Avg Time Held
6.1 quarters
Top 20 Avg Time Held
6.2 quarters

Top Sells

Rank Stock Value
1
DBRG
DigitalBridge
DBRG
+$9.35M
2
RGR icon
Sturm, Ruger & Co
RGR
+$1.88M

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.46%
2 Consumer Discretionary 16.75%
3 Healthcare 8.24%
4 Communication Services 5.37%
5 Real Estate 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MTN icon
1
Vail Resorts
MTN
$5.03B
$11M 11.2%
86,000
– –
2024 Q3
6 quarters
IVE icon
2
iShares S&P 500 Value ETF
IVE
$48.6B
$11M 11.13%
51,905
– –
2022 Q4
13 quarters
VEA icon
3
Vanguard FTSE Developed Markets ETF
VEA
$232B
$10.1M 10.29%
158,160
– –
2022 Q4
13 quarters
UNH icon
4
UnitedHealth
UNH
$334B
$8.12M 8.24%
30,000
– –
2025 Q4
1 quarter
VWO icon
5
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$6.9M 7%
127,630
– –
2022 Q4
13 quarters
IBB icon
6
iShares Biotechnology ETF
IBB
$10.5B
$5.93M 6.02%
35,095
– –
2022 Q4
13 quarters
IWC icon
7
iShares Micro-Cap ETF
IWC
$1.4B
$5.65M 5.73%
35,385
– –
2023 Q3
10 quarters
CNNE icon
8
Cannae Holdings
CNNE
$674M
$5.46M 5.55%
+480,600
New +$6.45M
2026 Q1
0 quarters
KRE icon
9
State Street SPDR S&P Regional Banking ETF
KRE
$3.61B
$4.14M 4.2%
63,510
– –
2023 Q3
10 quarters
SAFE
10
Safehold
SAFE
$854M
$4.02M 4.09%
297,477
– –
2025 Q2
3 quarters
MANU icon
11
Manchester United
MANU
$3.46B
$3.36M 3.42%
200,000
– –
2025 Q1
4 quarters
EWW icon
12
iShares MSCI Mexico ETF
EWW
$1.52B
$3.15M 3.2%
41,850
– –
2023 Q3
10 quarters
EWZ icon
13
iShares MSCI Brazil ETF
EWZ
$8.88B
$3.12M 3.17%
81,300
– –
2023 Q3
10 quarters
VB icon
14
Vanguard Morningstar Small-Cap ETF
VB
$78B
$2.88M 2.93%
11,010
– –
2023 Q3
10 quarters
EWY icon
15
iShares MSCI South Korea ETF
EWY
$27.5B
$2.48M 2.52%
20,155
– –
2023 Q3
10 quarters
CRGY icon
16
Crescent Energy
CRGY
$4.42B
$2.11M 2.14%
156,166
– –
2022 Q4
13 quarters
EWT icon
17
iShares MSCI Taiwan ETF
EWT
$12.7B
$1.95M 1.98%
27,435
– –
2023 Q3
10 quarters
BATRK icon
18
Atlanta Braves Holdings Series B
BATRK
$3.34B
$1.93M 1.96%
+45,130
New +$1.88M
2026 Q1
0 quarters
OCSL icon
19
Oaktree Specialty Lending
OCSL
$1.05B
$1.92M 1.95%
+170,100
New +$2.04M
2026 Q1
0 quarters
EWJ icon
20
iShares MSCI Japan ETF
EWJ
$23.6B
$1.7M 1.72%
20,100
– –
2023 Q3
10 quarters
GXC icon
21
State Street SPDR S&P China ETF
GXC
$448M
$1.56M 1.58%
16,750
– –
2023 Q4
9 quarters
DBRG
22
DELISTED
DigitalBridge
DBRG
– –
-609,500
Closed -$9.35M –
RGR icon
23
Sturm, Ruger & Co
RGR
$709M
– –
-57,500
Closed -$1.88M –

Similar funds

Michelson Medical Research Foundation's Q1 2026 Portfolio in Review

As of Q1 2026, Michelson Medical Research Foundation held 23 positions worth $98.5M, down 1.3% from $99.8M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Michelson Medical Research Foundation's Q1 2026 filing shows 3 new and 2 closed positions. Its largest new stake was Cannae Holdings: 480,600 shares worth $5.46M. The largest sale was DigitalBridge, an estimated $9.35M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 59% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Michelson Medical Research Foundation's largest Q1 2026 buy was Cannae Holdings: 480,600 shares worth $5.46M.
  • Michelson Medical Research Foundation fully exited DigitalBridge in Q1 2026, selling an estimated $9.35M.
  • Michelson Medical Research Foundation's ten largest holdings make up 73% of its $98.5M portfolio in Q1 2026.
  • Michelson Medical Research Foundation opened 3 new positions and closed 2 in Q1 2026.
  • Michelson Medical Research Foundation's portfolio value fell 1.3% quarter-over-quarter to $98.5M.

Based on Michelson Medical Research Foundation's 13F filing for Q1 2026, filed 15 May 2026.